Download PDF
Thromb Haemost 2000; 84(04): 689-694
DOI: 10.1055/s-0037-1614088
Review Article
Schattauer GmbH

Platelet and Platelet-derived Microparticle Surface Factor V/Va Binding in Whole Blood: Differences between Neonates and Adults

Alan D. Michelson
1   From the Center for Platelet Function Studies, Department of Pediatrics, UMass Memorial Health Care, University of Massachusetts Medical School, Worcester, MA, USA
,
Damodara Rajasekhar
1   From the Center for Platelet Function Studies, Department of Pediatrics, UMass Memorial Health Care, University of Massachusetts Medical School, Worcester, MA, USA
,
Francis J. Bednarek
1   From the Center for Platelet Function Studies, Department of Pediatrics, UMass Memorial Health Care, University of Massachusetts Medical School, Worcester, MA, USA
,
Marc R. Barnard
1   From the Center for Platelet Function Studies, Department of Pediatrics, UMass Memorial Health Care, University of Massachusetts Medical School, Worcester, MA, USA
› Author AffiliationsThe authors thank Drs. Barry S. Coller and John W. Fenton II for generously providing reagents.
Further Information

Publication History

Received 15 March 2000

Accepted after resubmission 16 May 2000

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

Summary

Platelet-derived microparticles (PDMP) appear to play a major role in the generation of procoagulant activity. In this study, we describe a novel flow cytometric method that allows direct evaluation of the procoagulant activity of PDMP and platelets in the physiological milieu of whole blood. The percent PDMP generated in response to calcium ionophore A23187 and calcium was increased in preterm neonates (67.5 ± 3.4%, mean ± S. E. M., n = 8, p <0.05) and term neonates (67.2 ± 2.7%, n = 7, p<0.05) compared with adults (49.5 ± 3.4%, n = 13). However, in preterm neonates A23187/calcium-induced binding of factor V/Va to PDMP and platelets (22.8 ± 5.6 fluorescence units) was markedly reduced (p <0.05) compared to term neonates (58.2 ± 7.2) and adults (50.6 ± 6.3). In preterm blood, A23187/calciuminduced binding of factor V/Va to PDMP and platelets returned to adult levels when: a) adult plasma, rather than autologous preterm neonatal plasma, was added; or b) factor V, but not factor VIII, was added to autologous preterm neonatal plasma. In summary: 1) We have developed a flow cytometric method for the direct detection of procoagulant PDMP and platelets in whole blood. 2) Compared to adults and term neonates, PDMP and platelets of preterm neonates bound markedly less factor V/Va (reflecting reduced procoagulant activity), because of a relative lack of factor V in preterm neonates. 3) This procoagulant defect in PDMP and platelets may contribute to the propensity of preterm neonates, but not term neonates, to intraventricular hemorrhage. 4) The percent PDMP does not necessarily reflect the degree of procoagulant activity of PDMP or platelets.

Key words

Platelets - platelet-derived microparticles - flow cytometry - neonates - factor V
 

  • References

  • 1 Zwaal RF, Comfurius P, Bevers EM. Platelet procoagulant activity and microvesicle formation Its putative role in hemostasis and thrombosis. Bioch Biophys Acta 1992; 1180: 1-8.
    CrossrefPubMedGoogle Scholar
  • 2 Bevers EM, Comfurius P, Dekkers DW, Harmsma M, Zwaal RF. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance. Biol Chem 1998; 379: 973-86.
    PubMedGoogle Scholar
  • 3 Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-12.
    PubMedGoogle Scholar
  • 4 Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991; 266: 17261-8.
    PubMedGoogle Scholar
  • 5 Wiedmer T, Shattil SJ, Cunningham M, Sims PJ. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990; 29: 623-32.
    CrossrefPubMedGoogle Scholar
  • 6 Lee YJ, Jy W, Horstman LL. et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thrombos Res 1994; 72: 295-304.
    PubMedGoogle Scholar
  • 7 Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry 1995; 34: 11625-34.
    CrossrefPubMedGoogle Scholar
  • 8 Pasquet JM, Dachary-Prigent J, Nurden AT. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996; 239: 647-54.
    CrossrefPubMedGoogle Scholar
  • 9 Miyazaki Y, Nomura S, Miyake T. et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456-64.
    PubMedGoogle Scholar
  • 10 Katopodis JN, Kolodny L, Jy W. et al. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997; 54: 95-101.
    CrossrefPubMedGoogle Scholar
  • 11 Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-38.
    PubMedGoogle Scholar
  • 12 Galli M, Grassi A, Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost 1996; 75: 427-31.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992; 119: 334-45.
    PubMedGoogle Scholar
  • 14 Michelson AD. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical studies. Blood Coagul Fibrinolysis 1994; 05: 121-31.
    CrossrefPubMedGoogle Scholar
  • 15 Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, ADP or an in vivo wound. Blood 1991; 77: 770-9.
    PubMedGoogle Scholar
  • 16 Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-15.
    PubMedGoogle Scholar
  • 17 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110.
    PubMedGoogle Scholar
  • 18 Michelson AD, Loscalzo J, Melnick B, Coller BS, Handin RI. Partial characterization of a binding site for von Willebrand factor on glycocalicin. Blood 1986; 67: 19-26.
    PubMedGoogle Scholar
  • 19 Furman MI, Benoit SE, Barnard MR. et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-8.
    PubMedGoogle Scholar
  • 20 Grau AJ, Ruf A, Vogt A. et al. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 1998; 80: 298-301.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost 1999; 81: 373-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87: 4925-36.
    PubMedGoogle Scholar
  • 23 Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD. Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997; 77: 1002-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72: 957-63.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Ahmann PA, Lazzara A, Dykes FD, Brann Jr AW, Schwartz JF. Intraventricular hemorrhage in the high-risk preterm infant: incidence and outcome. Ann Neurol 1980; 07: 118-24.
    CrossrefPubMedGoogle Scholar
  • 26 Bejar R, Curbelo V, Coen RW, Leopold G, James H, Gluck L. Diagnosis and follow-up of intraventricular and intracerebral hemorrhages by ultrasound studies of infant’s brain through the fontanelles and sutures. Peds 1980; 66: 661-73.
    PubMedGoogle Scholar
  • 27 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
    CrossrefPubMedGoogle Scholar
  • 28 Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88: 900-6.
    CrossrefPubMedGoogle Scholar
  • 29 Beverley DW, Pitts-Tucker TJ, Congdon PJ, Arthur RJ, Tate G. Prevention of intraventricular haemorrhage by fresh frozen plasma. Arch Dis Child 1985; 60: 710-3.
    CrossrefPubMedGoogle Scholar
  • 30 The Northern Neonatal Nursing Initiative [NNNI] Trial Group. A randomized trial comparing the effect of prophylactic intravenous fresh frozen plasma, gelatin or glucose on early mortality and morbidity in preterm babies. Eur J Pediatr 1996; 155: 580-8.
    CrossrefPubMedGoogle Scholar
  • 31 Volpe JJ. Intraventricular hemorrhage in the premature infant – current concepts Part II. Ann Neurol 1989; 25: 109-16.
    CrossrefPubMedGoogle Scholar
  • 32 Andrew M, Vegh P, Caco C. et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123: 285-91.
    CrossrefPubMedGoogle Scholar
  • 33 Udis BJ, Hickerson D, Bode AP. Vesiculation versus light scatter shifts in activated platelets. Cytometry. 1994 54. (abstr)
    PubMedGoogle Scholar